These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18004453)

  • 21. Progress and challenges in the identification of biomarkers for EGFR and VEGFR targeting anticancer agents.
    Le Tourneau C; Vidal L; Siu LL
    Drug Resist Updat; 2008 Jun; 11(3):99-109. PubMed ID: 18515176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modern molecular approaches to drug design and discovery.
    Ojima I
    Acc Chem Res; 2008 Jan; 41(1):2-3. PubMed ID: 18193819
    [No Abstract]   [Full Text] [Related]  

  • 23. The future of targeted therapies in ovarian cancer.
    Banerjee S; Gore M
    Oncologist; 2009 Jul; 14(7):706-16. PubMed ID: 19592450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug discovery approaches targeting the PI3K/Akt pathway in cancer.
    Garcia-Echeverria C; Sellers WR
    Oncogene; 2008 Sep; 27(41):5511-26. PubMed ID: 18794885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isoaspartate-glycine-arginine: a new tumor vasculature-targeting motif.
    Curnis F; Sacchi A; Gasparri A; Longhi R; Bachi A; Doglioni C; Bordignon C; Traversari C; Rizzardi GP; Corti A
    Cancer Res; 2008 Sep; 68(17):7073-82. PubMed ID: 18757422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting transcription factors for cancer therapy.
    Frank DA
    IDrugs; 2009 Jan; 12(1):29-33. PubMed ID: 19127502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNA-based therapy unlocks drugs within cancer cells.
    Erdmann J
    J Natl Cancer Inst; 2002 Dec; 94(24):1829-30. PubMed ID: 12488474
    [No Abstract]   [Full Text] [Related]  

  • 28. Targeting the delivery of glycan-based paclitaxel prodrugs to cancer cells via glucose transporters.
    Lin YS; Tungpradit R; Sinchaikul S; An FM; Liu DZ; Phutrakul S; Chen ST
    J Med Chem; 2008 Dec; 51(23):7428-41. PubMed ID: 19053781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting hypoxia in cancer therapy.
    Wilson WR; Hay MP
    Nat Rev Cancer; 2011 Jun; 11(6):393-410. PubMed ID: 21606941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxia-activated prodrugs forge ahead in cancer.
    Kling J
    Nat Biotechnol; 2012 May; 30(5):381. PubMed ID: 22565952
    [No Abstract]   [Full Text] [Related]  

  • 31. Chemical biology--understanding biology and advancing therapy.
    Schimmer AD
    Clin Invest Med; 2008 Oct; 31(5):E282-9. PubMed ID: 18980718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular damage and tumour response.
    Murray JC
    Eur J Cancer; 1992; 28A(10):1593-4. PubMed ID: 1389469
    [No Abstract]   [Full Text] [Related]  

  • 33. Prodrugs: pharmaceutical design and current perspectives.
    Jampilek J
    Curr Pharm Des; 2011; 17(32):3480-1. PubMed ID: 22074420
    [No Abstract]   [Full Text] [Related]  

  • 34. The chemical probe - scopes, limitations and challenges.
    Stark H
    Expert Opin Drug Discov; 2020 Dec; 15(12):1365-1367. PubMed ID: 32551991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated Approach to Match Cancer Drug with Molecular Imaging Probe to Quantify Targeting and Predict Response.
    Luker GD
    Radiol Imaging Cancer; 2020 Nov; 2(6):e209035. PubMed ID: 33778753
    [No Abstract]   [Full Text] [Related]  

  • 36. Membrane Proteins: New Approaches to Probes, Technologies, and Drug Design, Part II.
    Jaakola VP; Scalise M
    SLAS Discov; 2019 Dec; 24(10):941-942. PubMed ID: 31746681
    [No Abstract]   [Full Text] [Related]  

  • 37. Membrane Proteins: New Approaches to Probes, Technologies, and Drug Design.
    Scalise M; Jaakola VP
    SLAS Discov; 2019 Oct; 24(9):865-866. PubMed ID: 31539294
    [No Abstract]   [Full Text] [Related]  

  • 38. Perfecting probes.
    Nat Chem Biol; 2009 Jul; 5(7):435. PubMed ID: 19536099
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antiblastic agents: possibilities of their current use in tumor therapy].
    GROSSI F
    Clin Ter; 1959 Jan; 16(1):51-75. PubMed ID: 13639297
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular pathways and the hope of targeting angiogenesis.
    Sternberg CN
    Nat Clin Pract Urol; 2007 Sep; 4(9):470-1. PubMed ID: 17622236
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.